title: Merck to Present New Data from Its Innovative Cardio-Pulmonary Pipeline and Portfolio at AHA Scientific Sessions 2025
source: Yahoo
date: 2025-10-23
url: https://finnhub.io/api/news?id=d22db7dcdb81f4f791667389d8326b0168f8879427b60e14f72cbfee513922bf
RAHWAY, N.J., October 23, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from the company’s cardio-pulmonary portfolio and pipeline at the American Heart Association (AHA) Scientific Sessions 2025 in New Orleans, La., from November 7–10. Data presented at AHA highlight Merck’s continued dedication to advancing research across hypercholesterolemia and pulmonary arterial hypertension (PAH) to help address the global burd
